via Medical Xpress
A recently developed system for switching on the activity of genes could improve treatments for a broad range of neurological diseases. Esteban Engel, a researcher in viral neuroengineering in the Princeton Neuroscience Institute, and his team have developed new “gene promoters” – which act like switches to turn on gene expression – that promise to broaden the ability to deliver large genes and keep them active for long periods of time.
The research was published online this week in the journal Molecular Therapy: Methods & Clinical Development.
The team is developing these genetic switches for use in gene therapy, the practice of delivering new genes to replace or assist those that are faulty. Gene therapy is a promising strategy for many diseases, including disorders that involve the brain, such as Parkinson’s disease and Alzheimer’s disease.
To carry genes into cells, scientists take advantage of the fact that viruses come equipped with the machinery to gain entry to cells. Over the years, scientists have engineered viruses to deliver genes in ways that are safe and don’t cause disease. One of the viruses commonly used for this is the relatively harmless adeno-associated virus (AAV).
Engel and his team created new gene promoters that turn on genes after they have been transported into neurons – the cells of the brain and nervous system. The team designed their promoters by adopting attributes of promoters found in another class of viruses, the herpes viruses, which persist for years in the body by establishing a chronic infection in the nervous system.
The team’s engineered promoters occupy far less space than existing promoters used in gene therapy, allowing the transport of larger genes or multiple genes. The new promoters are also long-lasting, being less prone to repression or inactivation than most common promoters, so the therapeutic genes are active for long periods of time. These new promoters work with AAV as well as other viral and non-viral gene-delivery systems.
“These new promoters will allow us to deliver larger genes or multiple small genes,” Engel said, “and the genes can remain active for as long as they are needed.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Love Island’s Jack Fowler reveals secret battle with terrifying disease that left him paralysed and in a wheelchairon June 23, 2020 at 12:30 pm
JACK Fowler found fame on Love Island on the back of having the perfect body – but that same body was left paralysed and wheelchair-bound after he was struck down by a terrifying disease.
- Researchers quantify neurological implications of COVID-19on June 23, 2020 at 4:05 am
SARS-CoV-2 was first reported in Wuhan, China, in December 2019, and has been spreading massively throughout the world ever since.
- Zanardi's neurological condition 'remains serious' after crashon June 22, 2020 at 7:46 am
Alex Zanardi's neurological condition remains serious three days after the former Formula One driver suffered serious head injuries in a handbike crash, doctors treating the Italian Paralympic icon ...
- The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson’s Diseaseon June 22, 2020 at 2:24 am
Trimetazidine is contraindicated in movement disorders, however, a not negligible part of trimetazidine users is still patients with Parkinson’s disease (PD). The present study aimed to objectively ...
- Simple blood test could one day diagnose motor neuron diseaseon June 20, 2020 at 11:58 am
Scientists have identified a potential pattern within blood which signals the presence of motor neuron disease; a discovery which could significantly improve diagnosis.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- AAV Gene Therapy Pioneer Jude Samulski Develops Proprietary Regulated Gene Editing Systemon June 23, 2020 at 6:48 am
Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene therapy company, today announced that Jude Samulski, PhD, President, Chief Scientific Officer ...
- Genome-wide DNA methylation analysis of KRAS mutant cell lineson June 23, 2020 at 2:12 am
Oncogenic RAS mutations are DNA methylation changes that alter gene expression to drive cancer. Recent studies suggest that DNA methylation changes may be stochast ...
- Single-particle imaging of stress-promoters induction reveals the interplay between MAPK signaling, chromatin and transcription factorson June 23, 2020 at 2:07 am
Activated Protein Kinases integrate extracellular information in all eukaryotic cells. Using a live mRNA reporter, here the authors monitor transcriptional bursting in Saccharomyces cerevisiae upon ...
- What Is the Association Between Genotype, Phenotype in Patients With Retinoblastoma?on June 22, 2020 at 1:59 pm
Currently, retinoblastoma (RB) occurs in 1 of every 20,000 births, making it the most common pediatric intraocular neoplasm. The cancer results from biallelic inactivation of the RB1 tumor-suppressor ...
- Commentary: The world should know Iowa State’s Jack Trice, the only Black man with his name on a major-college stadiumon June 20, 2020 at 10:31 am
It’s an amazing honor to know that every time I step on that field, not only am I representing Iowa State and everything we stand for, but I’m representing someone who was courageous enough to fight ...